Literature DB >> 19755474

Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population.

Poorva Jain1, Paul Cockwell, Jane Little, Martin Ferring, Johann Nicholas, Nick Richards, Rob Higgins, Steve Smith.   

Abstract

INTRODUCTION: Accurate assessment of determinants of patient survival in end-stage renal disease is important for counselling, clinical management and resource planning. To address this we have analysed survival and risk factors for survival for patients treated for end-stage renal disease in a multi-ethnic UK population.
METHODS: A multicentre prospective observational cohort study was performed in four teaching hospital renal units serving a total population of four million people. A total of 884 consecutive patients treated with renal replacement therapy were studied. Cox proportional hazard modelling and adjusted survival curves were used to assess the impact of a range of variables on patients surviving dialysis for more than 90 days. Further analysis was undertaken to determine the likelihood of transplantation in different ethnic groups.
RESULTS: Survival was 29% after a mean and median follow up of 4.6 and 4.2 years, respectively. Factors associated with worse survival included the following: age; for each decade of life the relative risk (RR) of death was 1.52 (95% confidence intervals 1.41-1.65, p < 0.0001); comorbidity, one or two comorbid conditions, RR = 1.56 (95% CI 1.24-1.95, p < 0.001) and three or more comorbid conditions, RR = 2.34 (1.68-3.27, p < 0.001). Factors associated with better survival included the following: south-Asian ethnicity, RR = 0.6 (0.46-0.80, p < 0.001); renal transplantation, RR = 0.20 (95% CI 0.11-0.59, p < 0.0001) and glomerulonephritis as the primary renal disease, RR = 0.70 (0.50-0.97, p = 0.04). Factors associated with likelihood of transplantion were having a functioning fistula/peritoneal dialysis catheter at start of dialysis (RR 1.91, 95% CI 1.24-2.94, p = 0.003) and glomerulonephritis (RR 9.54, 95% CI 2.43-37.64, p = 0.001). Patients were less likely to receive if they were black (RR 0.10, 95% CI 0.02-0.34, p < 0.001), South Asian (RR 0.64, 95% CI 0.42-0.97, p = 0.037), diabetic (RR 0.06, 95% CI 0.01-0.23, p < 0.001) and had one or two comorbid conditions (RR 0.51, 95% CI 0.32-0.82, p = 0.06). Every decade increase in age was also associated with a lesser likelihood of transplantation (RR 0.55, 95% CI 0.49-0.61, p < 0.001). Discussion. Risk stratification at commencement of chronic dialysis may predict long-term survival in different patient groups. As expected ethnic minorities are less likely to receive a transplant and this should be addressed by the new waiting list prioritization. The better survival on dialysis in this population of patients with south-Asian ethnicity is unexplained and this requires further investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19755474     DOI: 10.1093/ndt/gfp455

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study.

Authors:  Hyunsuk Kim; Jung Nam An; Dong Ki Kim; Myoung-Hee Kim; Ho Kim; Yong-Lim Kim; Ki Soo Park; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

2.  Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.

Authors:  Sunil Bhandari; Natalie Ives; Elizabeth A Brettell; Marie Valente; Paul Cockwell; Peter S Topham; John G Cleland; Arif Khwaja; Meguid El Nahas
Journal:  Nephrol Dial Transplant       Date:  2015-09-30       Impact factor: 5.992

3.  Black ethnicity predicts better survival on dialysis despite greater deprivation and co-morbidity: a UK study.

Authors:  Nicholas Cole; Michael Bedford; Andrew Cai; Chris Jones; Hugh Cairns; Satish Jayawardene
Journal:  Clin Nephrol       Date:  2014-08       Impact factor: 0.975

4.  Inequalities and outcomes: end stage kidney disease in ethnic minorities.

Authors:  Emma Wilkinson; Alison Brettle; Muhammad Waqar; Gurch Randhawa
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

5.  The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.

Authors:  Stephanie Stringer; Praveen Sharma; Mary Dutton; Mark Jesky; Khai Ng; Okdeep Kaur; Iain Chapple; Thomas Dietrich; Charles Ferro; Paul Cockwell
Journal:  BMC Nephrol       Date:  2013-04-25       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.